Read more

April 27, 2021
1 min read
Save

DJO completes acquisition of MedShape

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

DJO announced it has completed the acquisition of MedShape Inc., a privately held orthopedic medical device company that provides innovative surgical solutions for foot and ankle surgeons.

“Based on our long-term success and deep relationships in both our prevention [and] recovery and recon segments, we made a strategic decision to meaningfully expand into the fast-growing foot and ankle market. We believe our acquisition of Star, Trilliant Surgical and now MedShape have created a strong position in the space and will create a rapid growth platform,” Brady Shirley, CEO of DJO, said in a company press release. “MedShape’s patented technology and growing suite of foot and ankle innovations complement our existing portfolio and strengthen our key strategic imperative of superior clinical outcomes.”

With its patented super-elastic nickel titanium (Nitinol) shape memory alloy and shape memory polymer technologies, the MedShape Inc. product line opens a new market entry for a suite of surgical solutions that actively participate in the bone healing process and creates new options for self-adapting foot and ankle implants, according to the release. The release also noted the acquired portfolio from MedShape Inc. includes innovative devices for fracture fixation, joint fusion and soft tissue injury repair that utilize biomaterial technologies designed to improve patient outcomes.

“As the industry leader in developing shape memory technologies and successfully applying that science to foot and ankle products, we have unbounded future potential,” Ken Gall, PhD, co-founder of MedShape Inc. and professor at Duke University, said in the release. “We are excited to continue developing and integrating this breakthrough science to expand into other areas of orthopedics leveraging DJO’s market leadership, patient outcome focus and commitment to product innovation.”